Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012)

Iridex (IRIX) recorded quarterly Liabilities from Discontinued Operations of 67000.0 in Q3 2012, down 15.19% quarter-over-quarter from 79000.0 in Q2 2012.

Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends

Iridex's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 67000.0 for Q3 2012.

  • In Q3 2012, Liabilities from Discontinued Operations changed N/A year-over-year to 67000.0; the TTM figure through Sep 2012 stood at 67000.0 (changed N/A YoY), while the FY2011 annual figure was 2663000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 67000.0 for Q3 2012 at Iridex, down from 79000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 2663000.0 in Q4 2011 to a low of 67000.0 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Iridex 19.91 Mn 15.31 Mn 4.74 Mn

Historic Data

Download Data
DateValue
Sep 29, 2012 67,000.00
Sep 29, 2012 67,000.00
Jun 30, 2012 79,000.00
Jun 30, 2012 79,000.00
Mar 31, 2012 259,000.00
Mar 31, 2012 259,000.00
Dec 31, 2011 2.66 Mn
Dec 31, 2011 2.66 Mn